A Pain Relief Trial Utilizing the Infiltration of a Multivesicular Liposome Formulation Of BupiVacaine, EXPAREL®: A Phase 4 Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal
Location: See all (3) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
Minimum Age: 18
Healthy Volunteers: No
• Male or female, 18 years of age and older
• Patients scheduled to undergo ileostomy reversal
• Ability to provide informed consent, adhere to study visit schedule, and complete all assessments.
University of Arizona College of Medicine
Florida Hospital d/b/a Colon & Rectal Surgery Center
University of South Florida
Start Date:January 2012
Completion Date:October 2012
Target number of participants:33
Active Comparator: Group 1
IV morphine sulfate (or Sponsor-approved equivalent), Standard of Care (SOC)